From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.
News
STAT+: Doudna talks cost, access issues looming over first CRISPR therapy
“How do we make sure that a technology like CRISPR — you know, no offense intended — is not just going to make a few people rich, but it’s going… […]
News
STAT+: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high
“We’ve lost an opportunity to have direct government purchases of hundreds of thousands of doses of generic Truvada at a lower cost to dramatically lower HIV infections,” said Peter Staley… […]
News
STAT+: Bay Area biotech uses AI to unlock RNA structures — and find new therapies in the process
A new Bay Area biotech is harnessing artificial intelligence to better understand and predict RNA structures in hopes of developing new therapeutics. […]
